a win for small–cell lung cancer: impower 133
Published 5 years ago • 3.5K plays • Length 6:33Download video MP4
Download video MP3
Similar videos
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
1:50
small cell lung cancer: interpreting data from impower133
-
3:08
impower133 and caspian trials for extensive stage sclc
-
5:06
impower133 in sclc
-
2:07
dr. chen on the impact of the pivotal impower133 trial on sclc
-
3:00
small-cell lung cancer: future directions in care
-
0:48
immunotherapy for patients with small-cell lung cancer
-
4:27
emerging treatment options for sclc
-
4:37
frontline therapy approaches for small cell lung cancer
-
8:11
first-line immunotherapy: impower133 regimen
-
3:45
addressing the aggressive nature of sclc
-
1:44
dr. liu on the checkmate-032 trial in sclc
-
0:28
adhesion dynamics of human non‐small cell lung cancer a549 cells on a 2d surface
-
5:46
optimal management of limited-stage sclc
-
6:32
the caspian versus impower133 regimen
-
1:40
dr. piotrowska on eligibility criteria for osimertinib in lung cancer treatment
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update